Clinical trial
Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In…
NCT00330616 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00330616 |
|---|---|
| Title | Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan |
| Official title | Clinical Evaluation of Bupropion SR (323U66)in Patients With Depression - Investigation in Elderly Patients With Depression |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder (MDD) |
| Intervention type | Drug |
| Interventions | 323U66 SR |
| Enrollment | 35 |
| Start date | May 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | May 29, 2006 |
| Last update posted | May 4, 2015 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: